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ABSTRACT 
In recent years there have been logarithmic upsurges of 
test demands placed on medical laboratories. Currently, there 
is a pre-existent and progressive shortage of medical tech-
nologists~ The widening gap has in part been closed by 
automation~ 
Automation is being heavily utilized to an increasing 
degree in most areas of the laboratory with enhanced accuracy 
and precision, decreased professional effort and significantly 
decreased cost to the patient as coincidental returns~ Through 
automation mass screening is being performed and maximum quality 
control can be exercised The urinalysis may be the last major 
hiatus still remaining. 
Inasmuch as the clinical laboratory scientist is dedicated 
to providing maximum excellence in patient care and because 
present methodologies (spot testing) in the area of urinalysis 
provide suboptimal clinical information, a study was undertaken 
to devise methodologies and essential equipment to improve 
laboratory diagnosis in the area& 
The routine urinalysis consisting of tests for pH, 
specific gravity, protein, sugar, hemoglobin and ketones was 
studiedo Two additional tests, creatinine and bilirubin, were 
ix 
also incorporated~ Color determination was investigated colori-
metrically and pH was studied with an electrometer. 
Methods uti zing microquantities of specimen were devised 
and adapted to two systems. One system was a urine analyzer 
designed and built especially for the study. The second system 
was fabricated from existing laboratory apparatus. 
The feasibility of automating urinalysis was established 
for both systems. Using healthy volunteers, the normal ranges 
and other pertinent data were established for each method. 
Pathologic specimens were included in the study. Comparison 
with existing spot tests proved the value of the automated 
quantitative approach~ 
Several innovations resulted from this study. The use of 
a double beam colorimeter eliminated possible background errors 
introduced by reagents or intrinsic pigments in the specimens. 
A new test for glucose was designed using a previously unre-
ported coenzyme analog which permitted linear colorimetric 
readings up to 1000 mg/IOO ml without pretreatment of the 
specimen Creatinine was determined for the first time on 
undiluted urine with a linear range up to 375 mg/IOO mI. A 
novel approach for analyzing bilirubin was developed" A 
relatively "noise free lf turbidimetric protein test system 
was adapted to continuous flow automation. Hemoglobin was 
estimated using O-dianisidine, with a degree of sensitivity 
five times greater than previously attainab An electronic 
system was proposed and fabricated which enabled three orders 
x 
of signal magnitude to be compressed into one scale sweep. 
In summary, the automation of the urinalysis was achieved. 
The quantitative automated approach appears technically and 
clinically superior to the qualitative manual method. 
xi 
INTRODUCTION 
There are two basic approaches to clinical laboratory 
testing~ These are quantitative analyses and qualitative 
estimationsB In general, the cost and effort input of quanti-
tative approaches are higho Qualitative, or "spot testing," 
has the advantage of low cost, but sacrifices accuracy 
(Feigle, 1966). In recent years, the trend has been away 
from qualitative approaches. Spot testing has been used mainly 
in mass screening efforts where the emphasis has been on early 
detection of disease processes, rather than in establishing 
definitive diagnosis and monitoring progress of disease states e 
Urinalysis, the assay of urine constituents, is the last major 
area in which qualitative testing is still widely performed 
(Kark et al., 1963). 
Automation is being increasingly utilized in virtually all 
areas of the laboratory, excepting that section concerned with 
urine studies (U. S. Government Printing Office, 1966). Di-
rect benefits resulting from automation include enhanced 
accuracy and precision, decreased professional effort, and 
significant decrease in cost to the patient (Lab World, 1968). 
Automation also provides rapid mass screening and maximum 
quality control capability. In addition, with the computer 
data acquisition available today, equipment can be monitored 
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and involved calculations may be derived. Data may be rapidly 
collated, retrieved and made available for vital differential 
diagnostic information (Pribor, Kirkham and Hoyt, 1968). 
Progress in the laboratory sciences has been characterized 
in recent years by logarithmic upsurges of test volume. Growth 
and expansion efforts haye been compounded by existent shortages 
of medical technologists to handle the increased work demands 
and research development has lagged ( U. s. Dept~ Health, Ed. 
and Welfare, 1969; U. s~ Dept. of Labor, 1967). Automation 
has helped alleviate this situation in all sections of the 
laboratory field; however, minimal progress has occurred in 
the field of urinalysisQ 
This static state of urinalysis invited studies on the 
feasibility of enhancing the accuracy, precision and clinical 
value of conventional test systems. It was soon recognized 
that these aims could best be achieved through automation and 
extended multiphasic analysis of urine metabolites. Since 
existing automated apparatus are primarily designed to analyze 
serum metabolites, experiments were initiated into the design 
and fabrication of new equipment and/or the total renovation 
of existing apparatus to handle the test systems. This was 
necessary because the chemical constituents and physical 
characteristics of urine differ greatly from serum. Challeng-
ing problems were repeatedly encountered, defined and for the 
most part solved. Promising new methodology and equipment was 
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devised. Although extended confirmatory experimentation re-
mains, initial findings indicate that quantitation of the 
urinalysis by an automated approach is feasible and has clini-
cal value. 
REVIEW OF LITERATURE 
Automation was first introduced into the clinical labora-
tory in 1957 (Skeggs, 1957). This prototype system performed 
a glucose analysis on samples of blood using a continuous flow 
principle~ Subsequent improvements led to the utilization of 
this scheme for multiple analysis, i.e., the pertormance of 
several tests simultaneously on a given specimen (Skeggs and 
Hochstrasser, 1964). Several automated chemical systems have 
been developed more recently. Each one entails a distinct 
method of handling the sample in a wet form. The Technicon 
Auto-Analyzer (Technicon Instruments Inc., Tarrytown, N. Y.) 
uses a flow-through method that allows sequential multiple 
analysis, whereas the Robot Chemist (Newman et al., 1968), 
Beckman DSA-560 (Rohte and Meyer, 1968), Hycel ~1ark X, du Pont 
ACA (Nadeau, 1968) and others have discrete systems in specific 
packets for the performance of tests in a wet phase. Instru-
ments have also been developed for partial semiautomation 
performance of a given test, esg., chloride is determined on 
an automatic titrator (Cotlove, Trantham and Bowman, 1958); a 
semiautomatic lithium, sodium and potassium system has been 
developed by Instrumentation Laboratory Inc., Boston, Mass.; 
the PBI and T4 Autoanalyzer for thyroid function studies has 
been marketed and total protein may be read refractometrically 
(Sunderman, 1944). 
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The automation of hematology progressed rather slowly. 
However, automation is evidenced in this area by slide strain-
ers, mechanized complete blood counts and indices (Gochman, 
Negersmith, and Weschler, 1966; Barnard et al., 1969), semi-
automated coagulation studies (Miale, 1965) and the automatic 
recording of osmotic cell fragility (Allen and Shields, 1966)~ 
Mass-screening for veneral diseases provided the impetus 
for automation in the serology sector (McGrew et al., 1968). 
The need for accurate and precise evaluation of drug therapy 
and antibiotic sensitivity resulted in further mechanized pro-
cedures (Pagarno, Haney and Gerke, 1962). Automation has also 
been extended to such time consuming tasks as changing air 
mixtures for anaerobic culture conditions (Cohen, 1967) and 
in typing specific organisms (Hochberg et al., 1966). Bacteria 
are now being studied by analysis of metabolites using gas 
chromatography (Mitruka and Alexander, 1968)m 
Automatic blood typing instruments and antibody titer 
measurements are available to detect and quantitate abnormal 
antibodies and identify red cell antigens (Morton and Pickles, 
1966; Sturgeon et al., 1966). These instruments may be used 
maximally in institutions where the blood banking volume is 
high. Time is conserved and the chance of gross error occurr-
ing in typing and crossmatching is lessened. 
Multiple channel systems made possible multiphasic test-
ing or mass screening (Reece, 1967). The term "multiphasic 
testing" implies the performance of chemical determinations, 
a complete blood count and a urine analysis on every patient 
evaluated on an out-patient basis. Reports of such studies 
have indicated favorable response by the physicians (Young 
and Duabe, 1966; Whitehead, 1966). 
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Urinalysis, one of the most common test batteries, is 
performed on every hospital admission, in every doctorVs of-
fice and in all out-patient clinics. It is an integral 
component of every health examination performed. The routine 
urinalysis consists of a pH determination, a specific gravity 
measurement, an occult blood or hemoglobin screen, a carbo-
hydrate test, a test for albumin and a microscopic examina-
tion of the sediment (Hepler, 1963). Baird in 1958 developed 
a test for the detection of phenylketonuria, which has been 
included in pediatric urinalysis routine 0 
Many clinicians feel that the urinalysis is the single 
most important examination performed on a given patient. In-
surance companies require that such an analysis accompany all 
physical examinations. Yet, with the exception of qualitative 
or crude semiquantitative tests, few advances have been made 
within the last decade. The lack of sensitivity in current 
testing procedures may have resulted in failure to detect 
incipient and subclinical disease processes. 
urine has over 300 constituents (Scott, Attrill and 
Anderson, 1967). These constituents result from normal body 
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metabolism or metabolic alterations. Fluctuations of these 
constituents can be related to a specific organ dysfunction, 
e.g., bile is associated with liver dysfunction, protein may 
indicate the beginning of existence of renal malfunction and 
ketone bodies are associated with metabolic acid-base im-
balance. Constituents and properties are cited b~low. Various 
methodologies are reviewed and evaluatedm 
I. BILIRUBIN 
Ordinarily bilirubin is not present in the urine but in 
certain diseases the conjugated component may be excreted. 
Accordingly, tests for urine bilirubin have been shown to be 
useful in the diagnosis and prognosis of biliary obstruction 
or diseases causing regurgitation of conjugated bile into the 
circulatory systems 
There are many tests for the detection of bile in the 
urinee These may be classified into four groupings: 
1. Observation of urine for the typical color of bili-
rubin, ioe., yellow, brown or greene 
2e Oxidation of bilirubin to give characteristically 
colored derivatives, ecgc, bilicyanin blue and biliverdin 
greenm Specific colors are produced with iodine or nitric 
acid (Godfried, 1934). Various adaptations of the Fouchet 
test, eog~, Harrison spot test and Watson strip test, wherein 
barium chloride is used to concentrate the bilirubin and 
Fouchet's reagent (ferric chloride-trichloroacetic acid) to 
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oxidize the material, have been proposed (Giordano and Winstead, 
1953; Musser, 1962). 
3. Diazotization, which is the coupling of bilirubin to 
a diazo compound Barium chloride is again used to concentrate 
the bilirubin and diazo reagents are then added to form azo-
bilirubin, which may turn blue, pink, or purple depending on 
the pH (Godfried, 1934). A tablet form of diazo reagent has 
been described (Free and Free, 1953) and in 1969 a dip stick 
method was introduced (The Bili Labstix, Ames COQ, Inc., 
Elkhart, Indiana) which incorporates a bilirubin test, utiliz-
ing the diazotization reaction. 
4e Dye dilution procedures which involve the blending 
of the yellow-brown color of bilirubin with some dye, such as 
methylene blue or methyl violet (Gellis and Stokes, 1945). 
Until recently the aforementioned qualitative tests were 
run only on request and not as part of the routine urinalysis~ 
Furthermore, their specificity and sensitivity varyQ For 
example, ferric chloride, which is a component of Fouchet 
reagent, also reacts with salicylates, and pigments other than 
bilirubin interferes with many tests (Thoma and Kitzberger, 
1948)e Dye dilution tests are sensitive only in the 2 mg/IOO 
ml range, as opposed to the ~05-0.l mg/IOO ml range the 
other tests. Diazo reactions appear to be the most specific 
and sensitive methods available for qualitative and semi-
quantitative estimations but do not provide reliable results 
in urine. All qualitative tests are generally formulated to 
detect abnormal presence of bilirubin (Henry, 1964b). 
9 
Quantitative estimations of urine bilirubin have been 
made utilizing the principles of oxidation and diazotization. 
A combination oxidation and diazotization method was intro-
duced which attempted to increase the specificity of the diazo 
reaction. Sodium hypochlorite was used as an oxidizer and 
Erhlich's reagent for the diazo reaction (Brereton and Lucia, 
1948). The procedure involves precipitation techniques and, 
therefore, is not readily automated. Direct diazotization of 
the urine yields brown colors and not true azobilirubin color. 
A recent modification of the diazo reaction using a copper-
azobilirubin complex shows promise (Michaelson, 1961). 
Automation of presently available techniques involves 
considerable preliminary handling of the specimen by way of 
precipitation, centrifugation or filtration. Investigations 
using a hypochlorite technique have shown possibilities. A 
modified direct hypochlorite technique was developed and 
adapted to automation. 
II. CREATININE 
Creatinine is a nonprotein nitrogenous hydrolytic product 
of creatine catabolism8 Determination of creatinine is of 
diagnostic value in a host of disease states (Searcy, 1969b). 
Increased amounts are found in the urine following muscular 
injury and decreased amounts are associated with glomerular 
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damage. It is present in the urine in amounts of 15-30 mg/kg 
body weight per day. Since the amount of creatinine formed 
under normal conditions is reasonably constant, determination 
of creatinine in 24 hour urine specimens serves as a rough 
estimate of the completeness of urine collection. The con-
centration of certain urine constituents are frequently 
equated to and reported in terms of units per milligram of 
urine creatinineo The very important creatinine clearance 
test requires both urine and serum creatinine values (Peterson, 
1967) • 
There are four methods in use for the estimation of 
creatinine: 
1. Modification of the Jaffe reaction, wherein creati-
nine treated with an alkaline picrate solution yields a bright 
orange to red color (Slot, 1965; Owen et aZ., 1954). 
20 The reaction of creatinine with 3,5 dinitrobenzoic 
acid in alkaline solution to give a purple rose color (Langley 
and Evans, 1936)0 
3. The conversion of creatinine to methylguanidine by 
O-nitrobenzaldehyde (van Pilsum et aZ., 1956). 
4. The estimate based upon the reaction of creatinine 
with 1,4-naphthoquinone-2-PQtassium sulfonate (Cooper and 
Briggs, 1961) .. 
The Jaffe reaction appears to be most suitable for adapta-
tion to an automated urine system. 3,5 dinitrobenzoic acid is 
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purported to be slightly more specific for creatinine; however, 
the purification of reagents and the length of the procedure 
make it impractical. The conversion of creatinine to methyl-
guanidine and the naphtoquinone reactions are too lengthy and 
difficult for routine laboratory uses or for automated proce-
dures. 
III. GLUCOSE 
Determination of glucose in both blood and urine has long 
been a challenge to clinical chemists. As a result, consider-
able effort has been exerted to develop better quantitative 
and qualitative tests. The clinical value of urine glucose 
studies needs little amplification. 
Many of the test methods are based on the ability of 
glucose to reduce copper and ferricyanide. Techniques employ~ 
ing the ferricyanide reaction are gasometric (Hawkins, 1929), 
photometric (Hoffman, 1937) and titrimetric (Rappaport and 
Eichhorn, 1950). Copper reduction methods have also used 
titration and photometry (Gray and Millar, 1953; Benedict, 
1909). Unfortunately, these methods are not highly speci c 
for glucose and the presence of other reducing substances may 
interfere (Searcy, 1969a). Another entry in the field of 
sugar chemistry is the condensation of aldosaccharides with 
primary aromatic amines, namely orthotoluidine. A colored 
compound is formed and its transmittance follows Beer's law 
and is relatively specific for glucose. Protein free filtrates 
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are not necessary unless high quantities of protein are pre-
sent (Dubowski, 1962). An incubation period of ten or more 
minutes at high temperatures is required in most reducing 
tests. 
Enzymatic systems employing glucose oxidase have proven 
to be more specific but removal of interfering substances, 
such as enzyme inhibitors, e.g., urates and free drugs, is 
necessary in urine. This system has also been automated 
(Logan and Haight, 1965) and employs O-dianisidine or O-tolidine 
as the chromogenic oxygen acceptor. Both the copper reduction 
technique and the glucose oxidation technique have been adapted 
to commercial tablet and paper forms for qualitative studies 
(Kasper and Jeffrey, 1944; Free et aZ., 1957). 
A newer system uses adenosine triphosphate (ATP) and 
hexokinase (HK) to convert glucose to glucose-6-phosphate, 
which then reacts with nicotinamide adenine dinupleotide 
phosphate (NADP) in the presence of glucose-6-phosphate 
dehydrogenase (G-6-PDH). 6-phosphogluconate and reduced 
nicotinamide adenine dinucleotide phosphate (NADPH) are 
formed. The reduction of NADP to NADPH is measurable and 
relates on a molar basis to the amount of glucose present. 
The system is reportedly interference free and highly specific 
(Peterson, 1968) and requires no pretreatment of the specimen. 
This makes it a logical choice for utilization in an automated 
urine system. Sensitive enzyme procedures such as this have 
indicated that about 90 percent of healthy people excrete 
glucose in amounts of 1-15 mg/IOO ml (Fine, 1965). 
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Investigation using Thio-NADP is place of, or in con-
junction with, natural NADP has shown great promise in provid-
ing sensitivity over a wide range. Furthermore, the test can 
be read in the visible range, making it possible to perform 
with conventional equipmentQ Experimental data was gathered 
and evaluated for the automation of the procedure. 
IV. HEMOGLOBIN 
Hemoglobinuria is defined as the presence of hemoglobin, 
or hemoglobin pigment derivatives, in the urine. Although 
hemoglobin molecules readily filter through the glomeruli, 
free molecules are rapidly complexed by haptoglobin and only 
limited amounts will be present in urine, except when plasma 
concentrations exceed 100 mg/IOO ml (Laurell and Nyman, 1957). 
When red cells have been shed into the urine, hematuria re-
sults and hemoglobin tests will be positive. Hemolytic 
episodes (Lynch et aZ., 1969), genito-urinary hemorrhage and 
glomerular disease are the most common causes of hemoglobinuriaQ 
A number of chemical tests have been devised to demonstrate 
the presence of submicroscopic quantities of blood in biologic 
fluids. Several methods are based on the color produced by 
oxidation reactions of iron-containing derivatives of hemo-
globin in the presence of hydrogen peroxide. These are the 
benzidine hyrochloride test (Cook, Free and Free, 1956), 
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benzidine base test (George, Thornton and Illingworth, 19551, 
O-tolidine test (Stone and Burke, 1934), Zwarenstein's test 
(Zwarenstein, 1949) and guaiac test (Reich, 1956). These 
techniques have been incorporated into a tablet (Watson-
Williams, 1955) and paper stick (Leonards, 1962). Although 
the reactions are similar, they differ markedly in sensitivity 
(Cook, Free and Free, 1956)e 
The use of a compound related to O-tolidine has been 
shown to be effective in staining electrophoretic patterns for 
haptoglobin and hemoglobin-haptoglobin complex quantitation. 
Color stability and sensitivity are both enhanced by use of 
the highly reactive O-dianisidine, whereas colors conferred 
by benzidine and O-tolidine fade within minutes and guaiacol 
is unstable (Neale, Aber and Northam, 1958; Owen, Silberman 
and Got, 1958; Jermyn and Thomas, 1954). O-dianisidine was 
selected for use in adapting a hemoglobin method to automation~ 
v. KETONE BODIES 
The three metabolic end products produced by lipolysis 
are usually referred to as ketone bodies. B-hydroxybutyric 
acid, acetoacetic acid and acetone are normally produced in 
small amounts and pathologically in large amounts. Approxi-
mately 25-35 percent of these ketones are acetoacetic acid 
and acetoneo 
Excretion of ketones in excess of 50 mgjday is considered 
pathologic (Van Slyke, 19l7)e Increased levels of ketone 
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bodies are encountered in conditions in which the metabolism 
of glucose is impaired or in which increased fat metabolism 
occurs. Increased concentrations of these are associated with 
acidotic states and from this standpoint the early detection 
of ketonuria is of value is therapeutic management. 
Quantitative methods developed to date are too complex 
to be of immediate value and may not be specific enough for 
the ketones concerned, nor adaptable to automation. The fol-
lowing reactions have been employed: 
1. Bisulfite binding, which is not specific for the 
ketone bodies (Klein, 1940)" 
2. Iodometric titration, which again is not specific 
and requires lengthy distillation (Rappaport and Baner, 1943). 
3. Mercuric sulfate precipitation is supposedly acetone 
specific but the length of time for performance is prohibitive 
(Van Slyke, 1917)~ 
4. The salicylaldehyde test is used to determine total 
ketone bodies by converting B-hydroxybutyric acid to acetone 
with sulfuric acid but the procedure is too lengthy (Behre, 
1940) fl 
5. An enzymatic test using B-hydroxybutyric dehydro-
genase is the only true specific test for B-hydroxybutyric 
acid (Williamson, Mellanby and Krebs, 1962). 
The quantitative tests mentioned are involved and non-
specific. Qualitative tests have been developed for quick 
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detection and semiquantitative estimations of ketone bodies 
(Riekers and Miale, 1958)e Ferric chloride, mercuric dyanide 
(Wallhauser, 1928), salycilaldehyde (Behre, 1940) and the 
widely accepted nitroprusside test (Rothera, 1908) have been 
used. 
Nitroprusside reactions have been incorporated into a 
tablet and paper strip form (Riekers and Miale, 1958)r, Both 
forms have gained wide acceptance in the laboratory as part 
of the urinalysis test and for serum estimations (Nash, Lister 
and Vobes, 1954). A colorimetric method for estimating 
acetoacetic acid using the nitroprusside test has also been 
introduced (Schilke and Johnson, 1965) and automated (Klein 
and Oklander, 1966). Since acetoacetic acid is fairly stable 
in urine at room temperature, the nitroprusside reaction was 
adapted to the proposed automated urinalysis system providing 
a quantitative, yet expeditious procedure. 
VIe TOTAL PROTEIN 
Proteinuria is the presence of protein in the urine. 
Normally, urine contains t~ace amounts of proteinaceous 
material but the amount is usually less than 250 mg for 24 
hours, or 40 mg/IOO mI. This amount is generally undetect-
able by any of the simple spot tests now in use (Oser, 1965)~ 
Routine determination of the protein concentration in the 
normal range would be useful in that minor changes may occur 
which could be clues to the beginning of a pathologic con-
dition. 
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Routine determinations for protein are qualitative or 
semiquantitative and serve only to differentiate the normal 
concentrations from an abnormal elevation~ Sensitivity varies 
between methods. Qualitative tests used include the acid 
ring test, heat and acetic acid test, sulfosalicylic and 
trichloroacetic acid precipitation tests. Commercial tests 
are available which incorporate the principles of precipita-
tion and the colorimetric effect of protein error of indicators 
(Free, Rupe and ~1etzler, 1957; Exton, 1923; Watson, 1964) 0 
Quantitative estimations are performed by the turbidi-
metric reading of protein, which has been precipitated with 
such agents as trichloroacetic acid, sulfosalicylic acid and 
polythionate. Methods incorporating the Biuret reaction are 
used but the sensitivity is not sufficient at low protein con-
centrations (Henry, 1964a). This prohibits use of the reaction 
in an automated urinalysis system. In this study, the sulfo-
salicylic acid reaction was adopted as a routine test system. 
VII. COLOR AND APPEARANCE 
Color determinations are a very important aspect of the 
routine urinalysis. Normal urine color varies from very yellow 
to dark amber. Urochrome is the chief pigment present and 
accounts for the yellow to reddish-yellow spectrum. 
The intensity of color provides a quick means of deter-
mining the concentrating capability of the kidney and the 
patient's state of hydration. Dilute urines are pale and 
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concentrated ones are darker$ Description of the color for a 
given specimen will vary with individual interpretation at 
least within the normal color range and, to some extent, in 
pathologic ranges (Frankel, 1963). A probable cause is dif-
ference in learning experiences in conjunction with varied 
vision capability. 
In physiologic conditions, urine may be of unusual co1oro 
Certain vegetative foodstuffs, such as rhubarb, senna and 
beets, confer pigment ranging from brown-yellow to red-browns 
Medications are also responsible for certain abnormal co1ors~ 
Pathologic conditions present abnormal colors ranging 
from dark yellow to brown-red in acute febrile diseases, to 
milky color seen in chyluria or purulent diseases of the 
urinary tract. Hemoglobin confers a red-brown color if pre-
sent. Bile yields an orange color (Baue~ Toro and Ackermann, 
1962) .. 
Elimination of error in color reporting requires the 
use of standards. Since color reporting is traditional and 
of some clinical signi cance, an automated urinalysis system 
should include it. Therefore, a colorimetric scan at three 
wavelengths was tested to ascertain the value of automated 
estimation. 
VIII.. pH 
The determination of pH in urine has long been considered 
a valuable clinical parameter~ Both mono and dibasic 
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phosphates are mainly responsible for the reaction. Monobasic 
phosphates contribute acid reaction, while dibasic forms allow 
for a more alkaline reaction c Organic acids contribute but a 
minor part in the overall pH~ Twenty-four hour specimens have 
a pH range of 4 c 8 to 8 c O with a mean around 6 0 Women tend to 
have a higher pH in the morning specimen than men (Waters, 
Sussman and Asscher, 1967) G 
Diet plays an important role in the reaction of the urinee 
After ingestion of meals the urine may be neutral or alkaline c 
This is due to the increased utilization of acid radicals in 
the digestive process and is often referred to as the alkaline 
tide~ Furthermore, ingestion of carbonates and citrus fruits 
also cause alkaline reaction in urine. Acid reactions are 
caused by cereals, cranberries, meats and plums. Therefore, 
the time of day and type of diet contribute to the reaction 
of urine and should be considered in the overall clinical 
investigation (Oser, 1965). 
Measurement of the urine reaction is helpful in determin-
ing some metabolic disorders and in the regulation of the 
reaction for therapeutic purposes (Bauer, Toro and Ackermann, 
1962) Q Respiratory and metabolic acidosis decrease urine pH 
and is cases where alkalosis is present, the urine is alkaline~ 
Treatment of genito-urinary infections with sulfalthiazole, 
sulfadiazone, sulfamerazine or certain antibiotics require 
that an alkaline medium be maintained for more effective 
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action. Also, patients prone to renal calculi must have an 
acid or an alkaline urine maintained depending on the type of 
calculi being formedc Phosphates and calcium are precipitated 
in alkaline urine and uric acid, calcium oxalate and cystine 
precipitate in acid urine~ 
At present, nitrazine or similar pH indicator paper is 
used for pH estimation. This is generally sufficient for 
purposes of screening and rough estimation~ Fresh urine 
should be used to avoid shifts in pH due to bacterial action. 
A pH meter with sing probe was used with the proposed auto-
mated system (Bradley and Benson, 1969)~ 
MATERIALS AND METHODS 
10 APPARATUS 
Since most commercially available automated equipment 
has been designed to analyze serum metabolites and constitu-
ents, these apparatus were considered suboptimal for the 
analysis of urine constituentsc For example, urine normally 
contains only trace amounts of certain materials such as 
glucose, protein, bile and hemoglobin, which are present in 
substantial quantities in blood and serum~ Yet, in pathologic 
states urine levels of many substances will exceed blood 
levels o Color, turbidity, inhibitors and physical character-
istics of urine are so variable as to be unsuited to conven-
tional analysis without considerable modification of technique 0 
Therefore, a major effort was initiated to design and 
construct a unique, automated device particularly suited to 
analyze normal and abnormal urine components and propertieso 
New and existing test methodologies were perfected to interface 
with the proposed apparatuso 
The proposed apparatus was designed and built in collab-
oration with Bio-Logics, Inc. of Salt Lake City, Utah. It 
was comprised of the following modules: 1) a disc sample tray 
that rotated the specimens into position for sampling and 
testing, 2) a sampling system, consisting of a pneumatically 
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driven arm that drew a specimen of urine and deposited drop-
lets (beads) of equal quantities in parallel rows on a moving 
belti 3) a nonwettable surface belt that served the purpose 
of conveying blank and test beads through the reagent bank to 
the readout; 4) a reagent bank, consisting of a series of 
containers fitted with plastic tubing that carried the re-
agents to small syringes~ A pneumatic pump operated each 
syringe, allowing preadjusted quantities of liquid to be dis-
pensed at timed intervals; 5) a micro-cuvette double beam 
spectrophotometer was designed and fabricatede The test beads 
were simultaneously picked up by capillary action and the op-
tical density was recorded on a strip recorder. Filters of 
appropriate wavelengths were indexed into position for each 
test: and 6) a dual purpose pH electrode connected to an 
electrometer measured the pH of the specimen (see Figures I 
and 2)0 
A control cam programmed each functional componentn After 
the beads had been depositro on the belt, the reagents were 
added at intervals designed to allow effective reaction to 
occur as needed for each teste The apparatus had capability 
to process 60 specimens per houro 
IIo FEASIBILITY TESTING 
The various modules were tested individually and, fol-
lowing assembly, as an integral unit. The final testing 




0 CD 0 


















I (OPT ION) I 







L - - r __ .J 
® ~I ® I~ 
" I ® I (OPTION) I I 
x/iO I X I 10 x I I 
.... t (OPTION) 
® I~ @ 
Figure 2 
hemoglobin standards. Fabrication delay and sensitivity 
problems precluded definitive; in depth study, of the total 
systemo 
IlIa ALTERNATIVE EQUIPMENT 
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Since certain of the new concepts incorporated into the 
equipment design were untested in clinical situations, a 
secondary system was designed using available laboratory 
modular components~ A continuous flow system was constructed 
from basic Technicon (Technicon Instruments Inc , Tarrytown, 
NoYo) and Beckman (Beckman Instruments IncQf Fullerton, 
Califo) elements Special manifolds were constructed for use 
with a single channel autoanalyzer e Manifold pumps were used 
to deliver reagents and specimens An autoanalyzer sampler 
was used to sequence and time specimen samplingn Dialysis 
was performed where needed using either a long or short 
SMA-l2-60 transit dialyzer. 
Optical density readings were obtained using a Beckman 
DB-G spectrophotometer with a ten inch linear-log recorder o 
The recorder was set for log mode at one inch per minute. 
Fifteen mm quartz flow-through cells were used with the ap-
paratus 
IVe TEST PROTOCOL 
Following initial feasibility studies using the urine 
analyzer it was elected to use the modified flow system 
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approach to generate experimental data and to evaluate the 
merits of the automated urinalysis and its associated refine-
ments~ Each test system was assembled and requisite reagents 
and standards were prepared in accordance with procedure 
detailed in the respective technical section~ The apparatus 
was activated and a zero base line was established~ Standards 
were processed and calibration curves were constructed~ Normal 
and pathologic centrifuged specimens were tested and repro-
ducibility and recovery studies were performed $ Baseline 
drift, intrinsic noise, specimen "carryover," possible 
chemical interference and optimal incubation and related 
sensitivity problems were studied for each procedure~ 
All specimens were analyzed by one or more reference pro-
ceduresn Glucose, ketones, protein, bile and hemoglobin were 
all presumptively tested using the Ames Bili-Lab-Stixs 
Creatinine was assayed by an automated method (Hunter, Degn 
and McGuire, 1968) and glucose was, in addition, estimated by 
a colorimetric procedure (Dubowski, 1962). All specimens in 
which a discrepancy was encountered were assayed by an ad-
ditional reference procedureQ These confirmative procedures 
included the Acetest for ketones, the sulfosalycylic acid 
turbidimetric test for protein, the Ictotest for bile and the 
Hematest for hemoglobine 
v~ TEST SPECIMENS 
Primary aqueous standards were prepared from reagent 
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grade chemicals 0 These were made up in serial concentrations 
and processed as specimens. Readings were then plotted against 
concentration and a calibration curve was drawn for each method. 
Standards were interspersed at various times to validate 
the stability of the methodologyo Preparation of standards 
for each metabolite is described in the respective methodology 
section~ 
Twenty-four hour urine collections from 17 normal subjects 
were used to establish normal values~ Sixteen patients were 
studied to determine the capability of the system to detect 
pathologic conditionso These patient specimens were assayed 
in the routine manner. Trained, experienced personnel inde-
pendently performed the prescribed qualitative tests c These 
tests included a dip stick test for protein, hemoglobin, 
ketone, glucose and bilirubinG 
VI. CREATININE 
Creatinine yields a measurable red color when reacted 
with picric acid in the presence of a strong alkali~ 
Creatinine + Alkaline Picrate ~ Red Tautomer of Creatinine 
A. Reagents 
1. Sodium hydroxide, N/2~ Dissolve 200 grams NaOH 
pellets in H20 Dilute to 1000 ml~ 
2~ Picric acid solution~ Add boiling water to 13 grams 
of dry crystalline reagent picric acid~ Stir until dissolved. 
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Cool and dilute to one liter and use the clear solution. Store 
in a brown bottle away from light. 
3 0 Stock creatinine solution o Transfer five grams of 
pure creatinine to a 100 ml volumetric flask and dilute to 
100 ml with N/IO HCl. Add two drops toluene. One ml contains 
50 mg creatinine. Dilute 10 ml of stock to 100 ml with dis-
tilled water~ Use this as a working stock standard& 
Diluted standards were ~epared as follows: 



















1. Assemble flow system in accordance with Figure 3 (see 
Figure 3) 0 
2. Establish a baseline with reagentso 
3 Perform single cycle analysis on standards and test 
specimens. 
4~ Plot a calibration curve of optical density vs~ 
concentration for each standard. Extrapolate unknowns from 
this graph. 
C~ Comments 
The undiluted specimens were mixed with NaOH as the diluent 




































































































































































one part picric acid and one part NaOH. The dialysis elimi-
nated the need for a blanking cycle. The transit time should 
be approximately six minutes~ 
VII. GLUCOSE 
Hexokinase and ATP phosphorylate glucose to glucose-6-
phosphate. Glucose-6-phosphate dehydrogenase then oxidizes 
glucose-6-phosphate to gluconolactone-6-phosphate. The co-
enzymes NADP and TNADP (ThiO-NADP) act as hydrogen acceptors 
and are reduced to NADPH-TNADPH. This reduction bears a 
direct molar ratio to glucose conversionG Absorbance of NADPH 
is read at 340 nm and TNADPH is read at 400 nm. The basic 
system using NADP only was described in detail by Peterson 
(1968). TNADP was used to facilitate visual reading and 
regulation of sensitivity. 







l~ Nicotinamide adenine dinucleotide (NADP) 1 mgo 
2~ Thionicotinamide adenine dinucleotide phosphate 
(TNADP) 12 mg. 
3. Adenosine triphosphate (ATP) 70 mg. 
4~ Hydrochloric acid olN. 
5~ Buffer: Tris buffer pH 8 0 0 2 e 43 Tris to 100 ml with 
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distilled watero Twenty-five ml of this solution mixed with 
29 ml .1N HCl will give a solution of pH 8. 
6. Hexokinase (HK). Ten international units. 
7. Glucose-6-phosphate dehydrogenase (G-6-PDH). Ten 
international units~ 
The above may be purchased in prepackaged units from 
Calbiochem Co., Los Angeles, California (Cagalog No o 869204). 
The TNADP solution must be made separately. The lyophilized 
material is available from Boehringer-Mannheim Co., San 
Francisco, California. The other reagents are also available 
commercially (Sigma Chemical Coo, St~ Louis, Mo.) and may be 
prepared individually~ 
The reagent mixture contained the following: NADP, ATP, 
HK and G-6-PDH. Additional NADP was added with TNADP. 15.5 
ml of buffer was added to the vial containing this material. 
The substrate should be prepared daily. 
8~ Standards: Stock solution contained 5 gm gluco~e per 
100 mle Dilutions were as follows: 
Working Stock ml Distilled H2O ml Concn. mg/IOO ml 
5 95 250 
2.5 97 e 5 125 
1.25 98 Q 75 62®5 
.625 99 Q 375 3l~25 
B~ Procedure 










































































































































































2& Establish a baseline with reagents. 
3. With the use of diaglysis a blank cycle was unneces-
sarYe Standards were cycled first, followed by specimens. 
4~ Plot graph of optical density standards vs. concen-
trations. Extrapolate unknowns~ 
CQ Comments 
Linearity up to 250 mg/IOO ml was achieved o This may be 
extended to 1000 mg/IOO ml, by changing the NADP-TNADP ratioQ 
A ratio of 15 parts NADP to one part TNADP will provide this 
range~ The substrate acted as the recipient stream. The 
reaction proceeded rapidly and was read in four minutes. 
VIlle HEMOGLOBIN 
Hemoglobin acts as a peroxidase to catalyze the oxida-
tion of colorless oxygen acceptors to chromogenic states in 
the presence of hydrogen peroxideo 
O-Dianisidine Hgb (peroxidase) Oxidized O-Dianisidine 
(Colorless) (Red-Yellow) 
AG Reagents 
1 Absolute ethyl alcohol& 
2e 0 5% hydrogen peroxide made from stock 3% solution. 
Should be prepared daily~ 
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3. Buffer pH 4.0 (Coleman certified buffer tablets). 
4. Working reagent: a) .1 gm ortho-dianisidine in 70 
ml ethanol; b) 10 ml buffer solution; c) 18 ml distilled 
water. 
5. Standards: Fresh blood cells were washed several 
times with normal saline. The cells were then lysed by re-
peated freeze and thaw. A hemoglobin content was then deter-
mined by a standard cyanometh-hemoglobin method and proper 
dilution made with 0.1 M saline to establish 10 gm/IOO mI. 
One ml of this stock solution was then diluted to 100 ml 
to make the working standard solution. Diluted standards were 
prepared as follows: 










Standards and reagents were refrigerated when not in use. 
Be Procedure 
1" Assemble flow system in accordance with Figure 5 (see 
Figure 5) .. 
2~ Establish a baseline with reagents. 
3~ Recycling for a blank was not necessary due to the 
extreme speciman dilution involved. Sampling was performed 
at 50 specimens/hour~ 




















































































































































Baseline drift may occur due to reagent darkening. Al-· 
lowance should be made for this by interspersing water washes 
between series of tests. If mixing problems occur, the alcohol 
content of the O-dianisidine reagent may be decreased. 
IX~ KETONE BODIES 
Sodium nitroferricyanide reacts with acetoacetic acid in 
the presence of an alkali to form a lavender to deep purple 
color (Rothera, 1908). 
Na. Nitroprusside + Acetoacetic + Oxidized acetoacetic acid (permanganate colored) 
Aminoacetic acid (glycine) is used to stabilize the color and 
to provide anions for the reaction to reach completion (Madonia, 
1963; Schilke and Johnson, 1965)~ Ammonium hydroxide poten-
tiates the reaction and prevents interference by cretainine 
(Rothera, 1908)" 
A. Reagents 
1. Ammonium hydroxide - concentrated. 
20 Dissolve 10 grams nitroferricyanide in distilled 
water and dilute to 100 ml~ 
3 0 Buffer-glycine-alkaline complex. Dissolve 4.26 gm of 
sodium phosphate dibasic anydrous and 7.5 gm of glycine in 
distilled water and dilute to 300 mI. Add 7.5 ml of concen-
trated ammonium hydroxide to the solution. 
4~ Standards: Three ml of ethyl acetoacetate were 
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diluted to 100 ml with 0 0 2 N sodium hydroxide and refrigerated 
4B hours at 4°C. The hydrolysate contains 236.3 roM/liter or 
30.B grams per liter. A working stock solution of 0.30B gm/IOO 
ml was prepared by diluting one ml of the hydrolysate to 100 
mI. The following standard solutions were prepared from this 
stock solution. 




Concn. mg/IOO ml 
3 0 0Bl 
6.16 
30.lB 
The standard solutions were stable for one week under 
refrigeration. 
BCll Procedure 
1. Assemble flow system in accordance with Figure 6 (see 
Figure 6). 
2. Establish the baseline with reagents. 
3. Begin sampling at 40 specimens per minute Q 
40 Plot a calibration curve of optical density vs. con-
centration for each standard. Extrapolate unknowns from this 
graph. 
C.. Comments 
Using a dialyzer eliminated the necessity of a blank 
cycle~ The nitroferricyanide, however, began to darken rapidly 
after two to three hours of use G Since this is the main color 











































































































































problem unless corrected for by use of controls and water 
washes. 
x. TOTAL PROTEINS 
Proteins are precipitated by sulfosalicylic acid. The 
degree of turbidity is proportional to the quantity of pro-
teins present (Henry, 1964a) G 
A~ Reasents 
l~ Salineo 0.85%0 
2G Sulfosalicylic acid 3%D Three grams sulfosalicylic 
acid in 100 ml of water. 
3 m H20, pH 1 with hydrochloric acid. 
4. Standard: A working standard of 100 mg/IOO ml was 
prepared from a stock human albumin standard of 25 gm/IOO mI. 
The following dilutions were then prepared: 













1. Asserr~le flow system in accordance with Figure 7 (see 
Figure 7)e 
2. Establish base ne with water and reagents. 
3. Begin sampling 50 specimens per hour. 
















































































































































blank. In the first cycle water of pH 1 was pumped through 
the reagent line. The optical density inherent in each urine 
is thus established~ 3% (w/v) sulfosalicylic acid is used in 
the second cycle. 
5. A graph was constructed with the standards. After 
subtraction of the blank optical density, the unknowns were 
extrapolated from the curve 0 
C. Comments 
A trap (inverted debubbler) was positioned prior to the 
flow cell to promote convection and eliminate large particles. 
Noise may be a problem if the trap is not positioned properly 
in the system. Linearity was established through 100 mg/IOO 
ml using a continuous ow system o Excessive noise is indica-
tive of high protein content and the sample should be diluted 
and repeatedo 
XI. BILIRUBIN 
Bilirubin absorbs maximally in the 440 nM range. The 
conjugated form is very labile and is readily oxidized with 
an ablation of red-yellow maxima. Dilute hypochlorite was 
used to effect this oxidationo The difference in absorption 
at 440 was equated to bilirubin concentration~ 
Bilirubin Oxidizing Agent 





1. Sodium hypochlorite 1% w/v solution. 
2. Standards: An ox bile solution containing .08 mg/IOO 
ml of bilirubin was used as a primary standard. Standards 
were stored in dark bottles and away from light. The following 
dilutions were then prepared: 
Working Stock ml Distilled H20 ml Concno mg/100 ml 
100 0 .08 
1 1 .. 5 .032 
1 4 .016 
B. Procedure 
1. Assemble flow system in accordance with Figure 8 (see 
Figure 8). 
2. Baseline,was established with reagents. 
3. A sampling rate of 30 specimens per hour was used. 
Both specimen and reagent streams were divided. One portion 
contained hypochlorite as clorox, the other, water. The 
blank and test specimens were run through a Beckman D-BG 
spectrophotometer. The usual reference side had the reaction 
and the sample side acted as the blank. 
4. Curves were drawn and unknown values were extrapolated. 
C. Comments 
Phasing of the two flow through cells presented little 
difficultYe Sufficient time must be allowed for the oxida-















































































































































I. URINE ANALYZER 
Due to unpredictable developmental and fabrication de-
lays, the urine analyzer was delivered in an untested, 
unfinished mode. Minor functional difficulties and limita-
tions were encountered in several components including: 1) 
modular interface was approximate; 2) the cuvet system filled 
imprecisely; 3) build-up required frequent cuvet clearing; 4) 
light source, path and window were suboptimal; 5) reagent 
delivery system lacked precision; 6) clean-out mechanism 
activated prematurely and removed unread specimens from the 
conveyor belt; 7) the sensing mechanism was below electronic 
noise levels, making it difficult to achieve test sensitivity 
at low concentrations; and 8) color, pH and conductivity chan-
nels were not incorporated at the time of testing. 
However, the evaluation study yielded invaluable infor-
mation including: 1) the merits of the double beam system were 
confirmed; 2) specimen and reagent utilization was minimal; 
3) a novel electronic system was developed with capability to 
measure optical density over three orders of magnitude; and 
4) feasibility of automating color and pH in a single modular 
operation was demonstrated. 
Color was read manually in the DB-G spectrophotometer at 
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660 nm, 520 nm and 450 nm. Preliminary results indicate that 
yellow color yielded elevated absorbance in the 520 nm range, 
reddish colors in the 450 nm range and blue pigments and tur-
bidity at 660 nm in accordance with the concept of reciprocal 
wavelength absorption (Henry, 1964c). Further evaluation 
needed to establish the clinical value and feasibility of re-
porting color in terms of wavelength absorptivity~ 
Comparative studies of pH were done using standard pH 
paper and pH metersQ Accuracy and sensitivity were enhanced 
by use of the electrometer~ 
The urine analyzer is in the process of minor redesign to 
eliminate certain of the problems cited above. Initial test-
ing has shown the feasibility this approach. The ensuing 
results were acquired using the alternative system. 
II. CREATININE 
Undiluted specimens were dialyzed in a short transit 
dialyzer~ The dialysate was reacted for six minutes with 
alkaline picrate. Three deviations from the conventional 
method are noted: 1) the use of undiluted urine; 2) a short 
incubation period; and 3) a fore shortened dialysise 
Sampling at a rate of 40 specimens/hour linearity was 
established through 375 mg/IOO mlQ The normal distribution 
was calculated at 20-340 mg/IOO. Values expressed for a 
24 hour period showed a range of 300-600 mg/IOO mI. A cor-
rection was made for body surface area in order to reduce 
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randomization of the values which were then expressed in grams 
per 24 hour period. Results indicated a somewhat lower value 
for women and children (see Table I). 
Replicate specimens were tested and yielded a precision 
of 3.61%. Additive studies indicated 100% recovery. Sensitivity 
of the procedure is 10 mg/IOO ml based on the calculated pre-
cision. 
Comparative tests were performed with an SMA 12/30 Auto-
Analyzer (Technicon Instruments Inc ot Tarrytown, NeY.) (Hunter, 
Degn and McGuire, 1968) e A 1:20 specimen dilution is required. 
Results were lower than those obtained with undilutes speci-
ments. Dilution error and the increased alkalinity of the 
final reaction mixture may account for the elevated values in 
the new procedureo 
Using the standard regression coefficient formula, Y = 
a + b X, ~ was calculated at -3074 mg/IOO ml and £ was cal-
culated at OQ82. ~,the Y intercept, indicates excellent 
correlation between the test and reference techniques; a 
slope of 0~82 suggests a somewhat greater recovery and cor-
relation between standard and specimen reactivity in the test 
procedure over the reference procedure 0 
III~ GLUCOSE 
A modification of the ATP-Hexokinase method with Thio-
NADPH allowed for establishment of a system which may be 
observed in the visible spectrum~ Dialysis enhanced the 
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TABLE I 
COMPARISON OF CREATININE VALUES 
SPECIMEN 24 HOUR 
mg/100 m1 mg/TOTAL gm/VOL gm/VOL NUMBER VOLUME SURFACE AREA 
1 M 1925 187 3620 3 0 62 1,,61 
2 M 2050 98 2010 2.01 1.15 
3 M 1650 102 1680 1 0 68 1 0 03 
4 M 775 325 2520 2.,52 1.40 
5 M 1810 98 1773 1.773 1.04 
6 M 1110 167 1854 1.854 1.04 
7 F 1175 63 .740 .740 .456 
8 F 860 153 1.316 1 0 316 .77 
9 M 1000 252 2 520 2.520 1.23 
10 M 910 260 2 0 370 2.370 1 .. 18 
11 C 480 77 .370 .. 370 .513 
12 F 1010 120 1.212 1.212 .637 
13 M 1120 225 2.,520 2.520 1.43 
14 M 1275 217 2.766 2.766 1.32 
15 F 580 195 1 0 131 1.131 .765 
16 M 825 315 2.598 2 598 1,,27 
17 F 1150 147 1.,680 1.680 1 .. 12 
M = Male, F = Female, C = Child. Note that randomization seen 
in values for mg/100 m1 is almost eliminated when corrected 
for surface area~ Twenty-four hour values are similar to 
those reported in the 1iterature~ 
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already sensitive and specific test and made blanking unneces-
sary. 
A normal range of 0-13.5 mg/IOO m1 (Figure 9) and 0-153 
mg/24 hr. was calculated for 16 patients. Beer's law is fo1-
lowed up to 1000 mg/100 m1. A precision value of 7.6% was 
established with replicate specimens. Additive studies indi-





















± 5 mg/IOO ml and may be increased or decreased by baseline 
shifts or by changing the ratio of NADP to TNADP in the re-
action mixturee 
Comparison studies were performed using the O-toluidine 
test as a reference test (Dubowski, 1962). Lower results were 
obtained with the enzymatic system by approximately one-half. 
It is probable that there are other substances present which 
react with ortho-toluidine and yield slightly increased values. 
Using a standard form for the coefficient of regression, 
Y = a + b X, a b value of 1.54 and an a value of 1.72 were ob-
tained. These indicated a close correlation between the two 
tests and any deviation from unity may be explained on the 
basis of experimental error and differences in specificity 
between manual and automated procedures. 
Sixteen randomized patient specimens were evaluated with 
the new procedure. These were run in series with the normal 
specimensc The enzymatic procedure detected two elevations, 
one at 25 mg/IOO ml and the other 250 mg/IOO mI. Studies 
performed with the routine procedures indicated one elevated 
glucose (see Table II). 
Experiments indicate that this test may be used for 
measuring quantities of glucose up to 1000 mg/IOO ml provided 
proper ratios of coenzymes are used. The values or normal 
range of 0-13 m 5 mg/IOO ml are comparable to the values reported 




























































































































































































































































































































































































































































































































































































































































































































































A range of 0-2.4 mg/IOO ml (see Figure 10) and 0-35 mg/ 
24 hours with the 17 normal subjects was observed. While 
most of the activity is probably due to hemoglobin, some may 
be attributable to nonspeci c perioxidase activity. 
Linearity of the calibration curve was established through 
100 mg/IOO mI. Precision of the method is 7.1%. Additive 













studies yielded a value of 100%, indicating that there are few 
substances present in urine that would interfere with the pro-
cedure~ Sensitivity based on the calculated values is approxi-
mately ±3 mg/lOO ml~ 
Thirteen patients were tested, one of which had an 
elevated hemoglobin. Routine analysis by dipstix'procedure 
failed to detect this elevation of 5 mg/lOO ml (s'ee Table II, 
page 52)" Again, the low range specificity of this method is 
validated and the estimated sensitivity is also sUbstantiated. 
Baseline shifts were encountered but compensated for by 
interspersing a water sample between each specimen. The re-
agent complex manifested a slight increase in absorptance. 
V" KETONES 
Linearity was followed through 125 mg/lOO mI. Normal 
ranges of 4-24 mg/lOO ml (see Figure 11) and 30-285 mg/24 
hours were established. Precision was calculated at 4 e 3% 
and 100% recovery was obtained 0 These normal values are above 
those reported in the literature. 
Twelve patient. specimens were run in series with the 
normals. Routine dip stick and a reference test indicated one 
elevation, which was quantitated by the present test system as 
37 mg/lOO ml (see Table II, page 52). Deterioration of the 
nitroprusside reagent resulted in a baseline shift. Break-
down occurs rather rapidly after two to three hours e This 
deterioration may cause a decrease in sensitivity, which is 
56 
estimated to be approximately ±8 mg/IOO mI. Correction for 
baseline shift was successfully achieved by interspersing water 
samples between a given series of specimens. 
VI. TOTAL PROTEIN 
The sulfosalicylic acid turbidimetric technique appro-






















Fi g. II 
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0-0.6 mg/IOO ml of protein (see Figure 12). Based on 24 hour 
volumes, this was calculated to be 0-9 mg/24 hours (see Table 
III, page 53). The reproducibility study on replicate speci-
mens yielded an 8.6% coefficient of variation. Recovery 
observed was 96.5%e Based on the noise level and calculated 
precision, sensitivity to ±5 mg/IOO ml could be reliably 
estimated. The reaction was linear through 100 mg/IOO mle 
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Fig.12 
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tested. Fourteen of these showed normal results based on the 
established range~ Two of the specimens had 9.43 mg/IOO ml 
and 2.71 mg/IOO ml respectively. These specimens were reported 
"negative ll by the reference procedure (see Table II, page 52). 
Large particles cause prohibitive "noise" in continuous 
flow systems. The trap effectively reduced the background 
fluctuation to acceptable levels® 
VII. BILIRUBIN 
A hypochlorite reagent was used to oxidize the bile pig-
ments presento Optical density readings were obtained using a 
dual flow system with a double beam differential read-outo 
This was done to avoid recycling the specimens and to enhance 
the sensitivity and reproducibility of the procedure~ Since 
the blank channel gave a stable color and the reaction channel 
was associated with a decrease in absorption, the blank stream 
was diverted through the sample cuvet while the reaction stream 
was passed through the reference side. This allowed for a 
positive scale deflection in the presence of bilirubin. 
The normal range established was -.08 to +.03 mg/IOO ml 
(see Table III, page 53, and Figure 13)~ Negative readings 
indicated the development of turbidity resulting from precipi-
tation of materials insoluble at high pH. Using an ox bile 
standard of 508 mg/IOO mI, a linear curve was established. 
Precision of 8% was estimatedo Recovery tests were not per-






















One patient specimen containing an estimated 1.01 mg/IOO 
ml of bilirubin gave an off scale reading. Comparative studies 
were performed using the Bili Lab-Stix and Ictotest. The 
Ictotest detected the presence of bile, but the dip stick was 
negative (see Table II, page 52). Another patient specimen 
which had been stored in the freezer was tested and caused 
full scale deflection on the chart recorder. This specimen 
was known to contain bile. Such a specimen would require 
several dilutions. 
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This study is not yet complete and the data presented is 
a preliminary investigation. Further investigation is being 
pursued to define the parameters of the system and to refine 
the procedure. 
DISCUSSION 
Routine urinalysis, as presently performed in clinical 
laboratories throughout the country, has afforded a means for 
relatively rapid and economic mass screening of patients. 
Significant changes in metabolism secondary to diseases such 
as diabetes, kidney infection, hemolytic anemias, liver 
disease and a variety of pathologic processes that alter the 
"normal" composition of urine are usually detected. The semi-
quantitative "spot tests" are simple to perform and require a 
minimum of experience or skill interpreting color changes 
indicative of pathologic processes. Through the conventional 
approach one technologist can process approximately 20 speci-
mens per hour (Ashton and Lashof, 1964). This includes addi-
tional confirmatory tests that may be necessary to further 
validate a result, e.g., the use of sulfosalicylic acid as a 
definitive test for albumin when detected on reagent strips. 
Reputed sensitivity of spot testing has been disclaimed 
(Kark et al., 1963; Oser, 1965); similarly, specificity and 
quantitative accuracy have been generally questioned (Kark et 
alQ, 1963)0 However, it will be presumed that the spot tests 
are capable of detecting materials when they are present in 
an abnormal amount. The human element may introduce errors 
by way of subjectivity or misinterpretation. Furthermore, 
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present methods necessitate the usually unpleasant and hazard-
our chore of handling the urine~ As virtually all other areas 
of laboratory science advance, clinical microscopy remains 
stationary and progressively its relative importance decreasess 
Two systems were evaluated for the purpose of achieving 
automation~ One system, the urine analyzer, was evolved from 
concept to feasible prototypeo The apparatus incorporates 
several advantages; however, further evaluation and modifica-
tion are needed before it is fully operational. Improvements 
could be made in the reagent dispensing system by increasing 
the volumes used or by converting to a hydraulic pneumatic 
method of dispensing~ Conveyor belts could be changed into a 
belt with cups carrying the reaction mixture. Flow-through 
cells could be used for the double beam system, enabling a 
better wash cycle, constant fill and longer light path~ All 
modules should be interfaced before any conclusions may be 
reached concerning the final operation~ With these few modi-
fications, the sensitivity of the chemical systems will be 
enhanced and sequential analysis may be accomplished. 
The second system evaluated was assembled from existing 
apparatus. Component parts were readily interfaced and 
adapted to the previously developed chemical test systems. 
One immediate disadvantage resulting from this approach was 
that sequential analysis could not be performed and, indeed, 
recycling to eliminate blank contribution was essential in 
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one test system. Individually, each test system proved valu-
able to productive quantitative data. Investigation may be 
pursued in the area of sequencing the individual system into 
a single operational mechanism. Both systems generated a con-
siderable volume of vital technical information, which in 
aggregate will contribute greatly to the final apparatus. 
Through automation it was possible to establish normal 
values for the metabolites tested o These were based on speci-
mens obtained from normal subjects. Furthermore, reporting of 
results in terms of milligrams of creatinine might eliminate 
possible dilution variables and preclude the necessity of 
accumulating a 24 hour specimen& This does not imply that 
the need for this type of study has been eliminated. Incor-
porating this approach, the methodology used in the automated 
process takes on greater import for two reasons: one, this 
will be a means of determining whether a fairly good 24 hour 
specimen was obtained; two, once the amount of creatinine 
per milliliter is determined, observed metabolite levels in 
random specimens can be corrected for dilution and concentra-
tion effect. 
The value of precise quantitation may be easily illus-
trated Studies may be performed on patients to establish 
trends of pathologic processes as they may occur. As an 
example, let us assume that a patient is suspect of having a 
paroxysmal nocturnal hemoglobinuriao A morning specimen is 
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obtained and subsequent specimens are taken at given intervals. 
Serial values will show a fluctuating trend which characterizes 
the disease~ This affords a research tool as well as a diagnos~ 
tic aid. In cases where proteinuria may be important, serial 
studies will indicate changes which will enable better diag-
nosis and management of the disease. Situations where metabolic 
acidosis may be a significant factor, or even a contributor to 
some pathologic process, the detection of serial ketone fluctua-
tions will help in the overall diagnosis and therapy. 
Physicians will benefit by having absolute values to 
evaluate Q At present, subjective values seen as two or four 
plus are reported~ The availability of metabolite concentra-
tion data will permit specific, precise therapy and will enable 
critical analysis of therapeutic response. It is even con-
ceivable that accurate analytic capability of urine metabolites 
will preclude some serum determinations. 
One of the most important aspects of any automated system 
over manual procedures is the decrease in overall cost. With 
the automation of urinalysis a decrease in the total cost for 
a test should be realized, despite the incorporation of ad-
ditional important testso As with chemical screening, the 
unit cost per test decreases with the number of tests performed. 
The laboratory scientist will accrue benefits also. The 
handling and manipulation of urine will be minimized. Work 
patterns and specimen flow can be made more efficient. 
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Statistical data can be gathered more efficiently and evalu-
ated. Accordingly, there will also be a decrease in false 
positive and false negative results due to human error and 
length of time before specimen is run. Conservation of per-
sonnel effort will enable extension into new laboratory 
efforts. Automation usually results in economy of space and 
expendibles. 
As an automated device generates results independent of 
technical observation, more time and study can be devoted to 
the all important microscopic examination of the urinary 
sedimente A decrease in the time lapse from collection to 
microscopic study will help preserve formed elements such as 
casts and red cells. Furthermore, bacteria, if present in 
limited amounts, will not be allowed time to multiply and 
greatly alter small quantities of measurable metabolites such 
as protein and glucose~ 
As stated earlier, the introduction of "mass production" 
into the clinical laboratory has introduced the concept of 
multiphasic screening~ An integral part of this screening 
procedure is the urinalysis test panel~ With the advent of 
automation in the area of urine study, a more accurate and 
precise screening can be accomplished~ Values from studies 
of serum, blood and urinalysis together can now present a 
more meaningful diagnostic profile for the clinician. 
Several major innovations have been incorporated in the 
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ibility study~ Threshold detection has been increased 
through the photometric readout (see Table IV)o Test systems 
have been modified or developed to meet certain mechanical 
restrictions or clinical requirementse One completely new 
modificqtion involves the glucose test system. 
The measurement or true glucose by any method has always 
met with formidable difficultiesm Quantitation by the ATP-
Hexokinaqe method of Peterson (1968) has been widely accepted; 
however, it has not been adapted to urine analysis. The great 
sensitivity of the test limited the effective range~ In addi-
tion, reaqings were made in the ultraviolet range at 340 nm. 
By adding Thio-NADP to the reaction mixture, the test can be 
read in the visible 400 nm rangee The NADP-TNADP ratio can 
be adjusted to permit a range excursion to over 100 mg/IOO ml 
without specimen dilutiono It is virtually interference free. 
The capability to detect minute elevations of urine glucose 
may facilitate the detection of early diabetes. 
Another new modi cation was the quantitation of bili-
rubin by direct oxidation with sodium hypochlorite. Normal 
values established for this method are comparable to the 
sensitivity required of spot tests (Henry, 1964b)~ This test 
provides a rapid means for quantitating and detecting incipi-
ent cases of hepatitis or other hepatic syndromes (Couch, 
1970) 






COMPARATIVE THRESHOLD DETECTION 
QUANTITATIVE QUALITATIVE 
mg/IOO ml mg/IOO ml 
350* 20* 
5 10 (Kark) 
67 
OBSERVED UPPER 











0 .. 02 
10 (Kark) 24 
20 (Kark) 0.,6 
0 0 05 (Kark) 0.03 
*Creatinine is normally present in high concentration. 
Conventional methods use great dilution to enable scale 
reading~ Values in the table are presented in terms of 
upper rather than lower threshold levels~ 
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in the detection of hemolytic disease, bleeding diathesis and 
numerous renal and lower urinary tract diseaseso O-dianisidine 
was employed to provide greater sensitivity than benzidine, the 
commonly used chromogen~ Dianisidine is approximately five 
times more sensitive to peroxidase activity than other benzi~ 
dine derivatives (Owen et aZ., 1958) ~ Quantities down to 3 mg/ 
100 ml are detectedo In this low range hemoglobin is usually 
present as the result of shed red cellsc Again, this affords 
an opportunity to quantitatively follow a patient either at 
the beginning of a process or during therapy. 
Ketone bodies are measured by means of a modi ed nitro-
prusside test. Ammonia hydroxide is added to prevent inter-
ference by creatinineo The test is sufficiently sensitive to 
detect low grade metabo c acidosis due to starvation, mal-
nutrition or poor glucose metabolismo Debilitated patients 
with complicating conditions cannot be adequately evaluated 
using qualitative testso Being able to follow a patient over 
a period of time with an inexpensive, but quantitative test, 
will enable better diagnostic and therapeutic capability. 
Total protein is usually measured on random morning 
specimens 0 For maximum information a 24 hour specimen is 
usually analyzed to establish increasing or decreasing path-
ologic trends~ The use of sulfosalicylic acid as the pre-
cipitating agent will allow for the detection of proteoses 
which are excreted during active progressive renal disease. 
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Furthermore, abnormal proteins, such as Bence Jones protein 
fragments, are important in the diagnosis of blood dysciasias. 
Serial urine examinations by quantitative protein tests in 
the third trimester of pregnancy may pick up early rises and 
enable the early diagnosis of eclampsia. Numerous other 
examples could be given~ 
Creatinine excretion has long been acclaimed as one of 
the best indicators of renal functiono On controlled diet, 
the amount excreted is constant for a given individual. Its 
determination has been used to check for the completeness of 
24 hour specimens (Oser, 1965). Assuming a normal diet, the 
average man excretes one to 1~8 gm per day~ If this is divided 
into random specimens and is checked accordingly, a good in-
dication of renal function can be obtained. In addition, the 
other measurements can be reported out in terms of creatinine 
concentration 0 For maximum consistency, the 24 hour creatinine 
excretion should be corrected for body surface area (see Table 
I, page 49). The degree of interference, as indicated by 
recovery studies, was not great~ 
Quality control may be maintained in the system by running 
known standards at regular intervals. This allows for cor-
rection of baseline drift and monitors the linearity and 
activity of the reagents. Primary or weighed in aqueous 
standards were useda They were prepared in stock concentrations 
from which working aliquots were diluted~ Use of lyophilized 
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standards, with most if not all materials included in one vial 
is feasible, thus eliminating the need for technical personnel 
to undertake the preparation of separate standards. 
Recovery studies indicate that the tests are reasonably 
specific and sensitiven Comparative studies between the spot 
tests and the automated methods also confirmed that automated 
procedures incorporated increased sensitivity over the manual 
methods (see Table IV, page 67)~ 
Introduction of automation into urinalysis with digital 
reporting will no doubt require a certain amount of re-
education e As quantitative data is accumulated for normal 
and pathologic states, the relationship between the various 
results must be related to the clinical picturee At a future 
time, the analysis and evaluation of urine metabolites will be 
of the same degree as that accorded serum findings~ 
Potential computer interfacing opens up the vast area of 
collating all information on a given disease processQ A 
patient can then be evaluated in terms of serum chemistry, 
urine chemistry, spinal fluid chemi , blood parameters 
and perhaps even tissue analysis~ The mUltiphasic screening 
will now be extended by more accurate, quantitative test 
procedures 0 With the potential of by computers, great 
masses of data may be gathered and intelligently evaluatede 
This will lead to better utilization of information and en-
hanced health care deliveryo Improved definition or patterns 
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will result in the identification of new syndromes and disease 
entities. Furthermore, mass screening programs will allow 
greater individualization of patient care, i.em, the storage 
of data on a particular patient from year to year will enable 
individualized normals to be developed, fording the physician 
more exact information on each individual patient. 
Additional tests which may be adapted to an automated 
urine analysis system include methods for phenylketonuria and 
other inborn errors of metabolism; a general ferric chloride 
test to detect false drug inhibitors; tests for chloride and 
other ions, urobilinogen, amino acids, bacteria, various 
enzymes, toxilogical derivatives and medications c This then 
opens up an area of new methodology to be evaluated on a long 
term basis. 
SUMMARY 
A study of the routine urinalysis was undertaken to deter-
mine the feasibility of automating the technique to achieve a 
degree of quantitation, accuracy, precision, sensitivity, 
specificity, rapidity, volume output and capability comparable 
to that attained in other laboratory sciences. Furthermore, 
in keeping with laboratory volume trends and medical scientif-
ic advance, it was not only highly desirable but tantamount 
that these objectives be attained. Although there is consider-
able justification for extending the test battery, this 
feasibility study was designed to include only those tests 
currently included in the routine urinalysis: pH, protein, 
ketone bodies, color, glucose, hemoglobin, bilirubin and 
specific conductivity. Creatinine was also incorporated 
as a potential means to allow more meaningful quantitation. 
Significantly modified chemical methods were adapted 
both to a specially designed automated device and to con-
ventional automated systemss The former apparatus deposited 
microquantities of specimen and reagent in the form of a 
droplet (bead) on a nonwettable continuous belt. Atvarious 
predetermined positions reagents were added. At the con-
clusion of a given interval the reaction mixture was carried 
into a double beam microcuvette photometer where the bead 
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entered the cuvette by capillary attraction and a graphical 
read-out of the voltage differential was recorded. One 
turbidimetric test, eight colorimetric reactions and one 
physical parameter were evaluated. Similarly, all methods 
used in the urine analyzer were adapted to a Technicon system 
comprised of existing apparatus, proving the versatility of 
the methodology and providing preliminary clinical data for 
evaluation. 
Minor imperfections and time restrictions precluded suc-
cessful testing of the specially designed urine analyzer: 
however, primary standards, normal and pathologic specimens 
were successfully tested on the conventional equipment 0 
Normal ranges, precision, recovery and comparative data were 
compiled and analyzed~ 
The feasibility of automating urinalysis was proven 
Quantitation of urine metabolites may be readily achievedo 
It appears reasonable that at some future time automated 
urine analysis will be routinely performed and that consider-
able patient benefit will accrue 
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